Angel Investment in HealthTech Startup
Epiphany helped deploy angel investment during COVID in April 2020 to Xylexa through its anonymous angel investor. Xylexa is a Pakistan-based, early-stage health-tech startup that has developed a computer-aided diagnostics (CADx) platform using Artificial Intelligence and an image processing approaches to assist healthcare providers with automated, accurate, timely, and cost effective medical image diagnoses. Using pathology-verified data, Xylexa’s patent-pending computer vision and ML algorithms analyze and interpret a patient’s medical image (mammogram) to detect cancers. Xylexa’s early detection methods optimize diagnostics, saving lives, cost, and time. Epiphany conducted due diligence and risk assessment, facilitated investor meetings, offered feedback and advice on how to strengthen fundraising documents, and participated in negotiation rounds to finalize the investment in Xylexa.
